It takes two types of meningitis vaccines to be fully immunized against one of the most common types of bacterial meningitis.

Few people have received both vaccines.


Get Informed. 

You've heard about meningitis. Maybe you have even received a meningitis vaccine. But you may not know as much as you think about what it takes to prevent one of the most common kinds of bacterial meningitis. 


Meningococcal disease is a life-threatening bacterial infection that can affect the lining of the brain and spinal cord, or it can cause an infection in the bloodstream - or both.

It is caused by 5 types of meningococcal bacteria - ABCWY - and can kill in a matter of hours.

2 separate meningitis vaccines are necessary to be fully immunized against the disease. Most have received the MenACWY vaccine. Few have received the MenB vaccine. 


Why Should You Care?

Our goal is to arm parents and young adults with the information to proactively talk to their healthcare provider about MenB and the vaccine available to help prevent it, and to encourage the medical community and high school, college and university administrators to talk to their patients and students about the MenB vaccine.


The Story Behind the Meningitis B Action Project

Five years ago, two mothers each lost their young, healthy daughters too soon to a now vaccine preventable disease, Meningitis B (known as MenB). High school senior Kimberly Coffey, 17, died one week before her graduation. College sophomore Emily Stillman, 19, died just 36 hours after her first symptoms. 

In the case of Kimberly and Emily, while both had received the MenACWY vaccine, the MenB vaccine
was not yet available to help protect them from MenB. Today, these mothers are joining forces to make sure other parents don’t needlessly suffer the same fate. 

The Kimberly Coffey Foundation and The Emily Stillman Foundation have come together to launch the Meningitis B Action Project. 

"Our job as parents is to put children in the safest position possible. Meningococcal vaccines provide that safety."

- Paul A. Offit, MD, Director of The Vaccine Education Center at The Children’s Hospital of Philadelphia and Professor of Pediatrics at The Perelman School of Medicine at The University of Pennsylvania  (Also Maurice R. Hilleman Professor of Vaccinology)